DE69535590D1 - Für den bradykinin-b1-rezeptor kodierende dna - Google Patents

Für den bradykinin-b1-rezeptor kodierende dna

Info

Publication number
DE69535590D1
DE69535590D1 DE69535590T DE69535590T DE69535590D1 DE 69535590 D1 DE69535590 D1 DE 69535590D1 DE 69535590 T DE69535590 T DE 69535590T DE 69535590 T DE69535590 T DE 69535590T DE 69535590 D1 DE69535590 D1 DE 69535590D1
Authority
DE
Germany
Prior art keywords
receptor
bradykinin
recombinant
dna encoding
host cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69535590T
Other languages
English (en)
Other versions
DE69535590T2 (de
Inventor
David L Linemeyer
John W Hess
Joseph A Borkowski
Kathleen K Bierilo
John G Menke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22861167&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69535590(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE69535590D1 publication Critical patent/DE69535590D1/de
Application granted granted Critical
Publication of DE69535590T2 publication Critical patent/DE69535590T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69535590T 1994-04-15 1995-04-10 Für den bradykinin-b1-rezeptor kodierende dna Expired - Lifetime DE69535590T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/229,418 US5712111A (en) 1994-04-15 1994-04-15 DNA encoding bradykinin B1 receptor
US229418 1994-04-15
PCT/US1995/004464 WO1995028474A1 (en) 1994-04-15 1995-04-10 Dna encoding bradykinin b1 receptor

Publications (2)

Publication Number Publication Date
DE69535590D1 true DE69535590D1 (de) 2007-10-18
DE69535590T2 DE69535590T2 (de) 2008-05-29

Family

ID=22861167

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69535590T Expired - Lifetime DE69535590T2 (de) 1994-04-15 1995-04-10 Für den bradykinin-b1-rezeptor kodierende dna

Country Status (8)

Country Link
US (4) US5712111A (de)
EP (1) EP0757716B1 (de)
JP (1) JP2001506481A (de)
AT (1) ATE372375T1 (de)
CA (1) CA2187740C (de)
DE (1) DE69535590T2 (de)
ES (1) ES2292168T3 (de)
WO (1) WO1995028474A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712111A (en) * 1994-04-15 1998-01-27 Merck & Co., Inc. DNA encoding bradykinin B1 receptor
SE9602822D0 (sv) * 1996-07-19 1996-07-19 Astra Pharma Inc New receptor
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6469150B1 (en) * 2000-05-22 2002-10-22 Pharmacopeia, Inc. Cloning and characterization of genes encoding bradykinin B1 receptor homologues from five mammalian species
WO2003016495A2 (en) * 2001-08-20 2003-02-27 Merck & Co., Inc. Transgenic rodents as animal models for modulation of b1 bradykinin receptor protein
EP1673438A4 (de) * 2003-10-08 2009-06-17 Merck & Co Inc Menschliches b1-bradykininrezeptorprotein selektiv exprimierende transgene nager
JP2008539260A (ja) * 2005-04-25 2008-11-13 アムジエン・インコーポレーテツド ポロゲンを含む生分解性プチド徐放性組成物
EP2646471A2 (de) * 2010-12-03 2013-10-09 Diamedica Inc. Monoklonaler antikörper gegen den bradykinin-b2-rezeptor (bkb2r)
WO2013173923A1 (en) 2012-05-25 2013-11-28 Diamedica, Inc. Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
CA2880085C (en) 2012-06-04 2021-09-07 Diamedica Inc. Human tissue kallikrein 1 glycosylation isoforms
KR20190122706A (ko) 2017-03-09 2019-10-30 다이어메디카 인코포레이티드 조직 칼리크레인 1의 투약 형태

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712111A (en) * 1994-04-15 1998-01-27 Merck & Co., Inc. DNA encoding bradykinin B1 receptor

Also Published As

Publication number Publication date
ES2292168T3 (es) 2008-03-01
US6307027B1 (en) 2001-10-23
ATE372375T1 (de) 2007-09-15
EP0757716A4 (de) 1999-07-21
US5965367A (en) 1999-10-12
EP0757716B1 (de) 2007-09-05
EP0757716A1 (de) 1997-02-12
CA2187740A1 (en) 1995-10-26
US5712111A (en) 1998-01-27
WO1995028474A1 (en) 1995-10-26
JP2001506481A (ja) 2001-05-22
CA2187740C (en) 2010-06-29
US20030036633A1 (en) 2003-02-20
DE69535590T2 (de) 2008-05-29

Similar Documents

Publication Publication Date Title
ATE282087T1 (de) Modifiziertes enzym mit lipolytischer aktivität
DE69635455D1 (de) Dna kodierend für glutaminsäure-gesteuerte chloridkanäle
DE69535590D1 (de) Für den bradykinin-b1-rezeptor kodierende dna
ES2009590A6 (es) Metodo de preparacion de proteina de cadena pesada del factor tisular humano.
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
DE69531302D1 (de) Zellsystem mit einer spezifischen wechselwirkung von peptid-bindenden paaren
IL193919A0 (en) DcR3 POLYPEPTIDE A TNFR HOMOLOG
EP0871702A4 (de) Cytokin lerk-7
KR970702917A (ko) Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체
ATE364695T1 (de) Gekürzte lösliche typ-i-rezeptoren für tumor- nekrose-faktor
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
ATE233788T1 (de) Interleukin-15-rezeptoren
DK0804558T3 (da) Tripeptidylaminopeptidase
DE69435020D1 (en) Protein-tyrosin-phosphatase ptp-s31
MX9304769A (es) Subfamilia ptp-d de fosfatasas de la proteina tirosina.
ATE360695T1 (de) Cortistatin: neuropeptide, zusammensetzungen und methoden
CA2032167A1 (en) Dna coding for protein binds to enhancer of.alpha.-fetoprotein gene
FR2716205B1 (fr) Récepteur galanine, acides nucléiques, cellules transformées et utilisations.
DE60033297D1 (de) Für die humane untereinheit 5-ht3-c des serotoninrezeptors 5-ht3 kodierende dna
ATE316138T1 (de) Rekombinante expression von s-layer-proteinen
AU2172597A (en) Protein phosphatase-1 catalytic subunit interactions
ATE191223T1 (de) Verwendung von zelladhäsions-peptiden zur modifikation des haftungsvermögens eukaryontischer zellen untereinander
DE60132571D1 (de) Für den menschlichen vanilloid-rezeptor vr3 kodierende dns
FR2697850B1 (fr) Nouveaux polypeptides ayant une activité de récepteur opioïde, acides nucléiques codant pour ces polypeptides et utilisations.
DE60129688D1 (de) Die menschliche beta-1a-untereinheit des potential-abhängigen natriumkanals und deren verwendungen

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: MERCK SHARP & DOHME CORP., RAHWAY, N.J., US

8328 Change in the person/name/address of the agent

Representative=s name: MARKS & CLERK (LUXEMBOURG) LLP, LUXEMBOURG, LU